Recruiting

Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment

Sponsor:

Ottawa Hospital Research Institute

Code:

NCT03677557

Conditions

Primary Immunodeficiency Disease

Secondary Immunodeficiency

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

16,5% Cutaquig

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information